Uwe Roehrhoff - Gerresheimer AG Insider

GRRMF -- USA Stock  

USD 82.05  0.00  0.00%

Member of the Management Board responsible for Moulded Glass Division

Mr. Uwe Roehrhoff is Chief Executive Officer, Member of the Management Board responsible for Moulded Glass Division of Gerresheimer AG since June 22, 2010. He was with the Company since 1991. He is also Chairman of the Supervisory Board at Gerresheimer Tettau GmbH, Gerresheimer Regensburg GmbH, Gerresheimer Glass Inc. and Gerresheimer Momignies S.A. He is Member of the Supervisory Board at Gerresheimer Queretaro S.A. and until April 19, 2011 he was Member of the Supervisory Board at Kimble Chase Life Science and Research. He initially worked in Group Controlling before moving in 1996, to the American subsidiary, where he was responsible for the American plants. In 1998, he took over the management of the Moulded Glass Division on an international level before assuming responsibility for the whole worldwide glass business in 2001. At the same time he became CEO of the American subsidiary Gerresheimer Glass Inc. In 2003, he was appointed to the Management Board of the Gerresheimer Group. Since its restructuring at the start of 2007 he was responsible for the Moulded Glass Division and the Life Science Research Division. He started his career in the finance department of Scheidt Bachmann GmbH. He holds a business administration studies degree from Universitaet zu Koeln.
Age: 54  Executive Since 2010      
49 211 6181 00  http://www.gerresheimer.com

Management Efficiency

The company has return on total asset (ROA) of 4.24 % which means that it generated profit of $4.24 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 17.22 % meaning that it generated $17.22 on every $100 dollars invested by stockholders.
The company has accumulated 1.26 B in total debt with debt to equity ratio (D/E) of 124.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Gerresheimer AG has Current Ratio of 1.09 suggesting that it is not liquid enough and may have problems to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. The company was founded in 1864 and is headquartered in Dsseldorf, Germany. Gerresheimer AG operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 9773 people.Gerresheimer AG (GRRMF) is traded on OTC Market in USA. It is located in Klaus-Bungert-Strasse 4 and employs 9,773 people.

Gerresheimer AG Leadership Team

Heike Arndt, Executive
Peter Noe, Executive, Ph.D
Katja Moegel, Executive
Francesco Grioli, Chairman
Axel Herberg, Executive
Anke Linnarzt, Director
Gerhard Schulze, Chairman
Andreas Schuette, Executive
Franz Hartinger, Executive
Eugen Heinz, Executive
Seppel Kraus, Executive
Lukas Burkhardt, Executive, Ph.D
Andrea Abt, Executive
Severine Camp, Director
Markus Rocholz, Executive
Christian Fischer, CEO
Lydia Armer, Executive
Karin Dorrepaal, Executive, Ph.D
Uwe Roehrhoff, Executive
Theodor Stuth, Executive
Rainer Beaujean, CFO
Udo Vetter, Executive
Sonja Apel, Director
Paul Schilling, Executive
Katja Schnitzler, Executive

Stock Performance Indicators

Current Sentiment - GRRMF

Gerresheimer AG Investor Sentiment
Macroaxis portfolio users are indifferent in their judgment towards investing in Gerresheimer AG. What is your judgment towards investing in Gerresheimer AG? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.